Target Identification
and Validation
The advent of fast and reliable next-generation technologies for the genomic and proteomic characterization of biological specimens has contributed to the identification and validation of a wealth of targets that can be potentially exploited for treating cancer. However, an in-depth molecular understanding of cellular processes is required to transition potential targets into pharmacological candidates.
Identify and Validate the Function of Biological Targets
At Crown Bioscience, we use a comprehensive tool set to determine the biological functions of each target as well as the consequences of pharmacological intervention.
Accelerate target ID and validation with 500+ validated cell lines and exclusive HUB organoids.
Unlock target-specific biomarkers and assess your agent’s impact on tumor growth with our unique models.
Access IRB-approved human biospecimens preserving molecular fidelity for breakthrough oncology research.
Reveal new drug targets with high-quality genomics and transcriptomics backed by automated, reproducible workflows.
Confidently model cancer and assess drug efficacy with our CRISPR-licensed platform.
Leverage high-resolution MS-based proteomics for sensitive, reproducible insights into complex biology.
Discuss Your Target ID and Validation Project
From in vitro and in vivo models to in silico insights, genomics, proteomics, and exclusive biobank resources, we deliver the integrated solutions you need to discover, validate, and advance the next generation of therapies. Contact us today to accelerate your breakthroughs.
